Liste non exhaustive de références
bibliographiques
(mise à jour : 7 octobre 2002)
|
DERNIERES REFERENCES MISES EN LIGNE (7 octobre 2002) Campbell C., MacPhail C. (2002). Peer education, gender and the development of critical consciousness: participatory HIV prevention by South African youth. Social Science & Medicine, 55 (2): 331-345. [Abstract]. Capaldi D.M., Stollmiller M., Clark S., Owen L.D. (2002). Heterosexual risk behaviors in at-risk young men from early adolescence to young adulthood: prevalence, prediction, and association with STD contraction. Developmental Psychology 2002, 38 (3): 394-406. [Abstract]. Crosby R., DiClemente R.J., Holtgrave D.R., Wingood G.M. (2002). Design, measurement, and analytical considerations for testing hypotheses relative to condom effextiveness against non-viral STIs. Sex Transm Infect, 78: 228-231. Des
Jarlais D.C., Semaan S. (2002). HIV Prevention Research: Cumulative
Knowledge or Accumulating Studies? Eke A, Peersman G., Semaan S., Hylton K., Kiiti N., Sweat M.D. (2002). Acquisition and Review of Non-U.S.–Based HIV Risk Reduction Intervention Studies. JAIDS, 30: S51-S55.[Accès au numéro online présentant l'article complet]. Elwy A.R., Hart G.J., Hawkes S., Petticrew M. (2002). Effectiveness of interventions to prevent sexually transmitted infection and human immunodeficiency virus in heterosexual men. A systematic review. Arch Intern Med, 162 (16): 1818-1830. [Abstract] [Full text]. Fenton K.A. , Chinouya M., Davidson O., Copas A. (2002). HIV testing and high risk sexual behaviour among London’s migrant African communities: a participatory research study. Sex Transm Infect, 78: 241-245. [Abstract] Greco M., Brownlea A., McGovern J. (2001). Impact of patient feedback on the interpersonal skills of general practice registrars: results of a longitudinal study. Medical Education, 35 (8), 748-756. [Abstract]. Hedges L.V., Johnson W.D., Semaan S., Sogolow E. (2002). Theoretical Issues in the Synthesis of HIV Prevention Research. JAIDS, 30: S8-S14.[Accès au numéro online présentant l'article complet]. Hobfoll S.E., Jackson A.P., Lavin J., Johnson R.J., Schroder K.E.E.E. (2002). Effects and generalizability of communally oriented HIV-AIDS prevention versus general health promotion groups for single, inner-city women in urban clinics. Journal of Consulting and Clinical Psychology, 70 (4): 950-960. [Abstract]. Hugen P.W.H., Langebeek N., Burger D.M., Zomer B., van Leusen R. et al. (2002). Assessment of Adherence to HIV Protease Inhibitors: Comparison and Combination of Various Methods, Including MEMS (Electronic Monitoring), Patient and Nurse Report, and Therapeutic Drug Monitoring. JAIDS, 30 (3): 324-334. [Abstract]. Kanshana S., Simonds R.J. (2002). National program for preventing mother–child HIV transmission in Thailand: successful implementation and lessons learned. AIDS, 16 (7): 953-959. [Abstract]. Kresina T.F., Flexner C.W., Sinclair J., Correia M.A., Stapleton J.T., et al. (2002). Alcohol use and HIV pharmacotherapy. AIDS Research and Human Retroviruses, 18 (11): 757-770. [Abstract]. Leigh B.C. (2002). Alcohol and condom use. A meta-analysis of event-level studies. Sexually Transmitted Diseases, 29 (8): 476-482. [Abstract]. Miles K. (2002). The historical role and education of nurses for the care and management of sexually transmitted infections in the United Kingdom: 1 Role. Sex Transm Inf 2002, 78 (4): 292-297. [Abstract]. Miles
K. (2002). The historical role and education of nurses for the care
and management of sexually transmitted infections in the United Kingdom:
Education and training. Sex Transm Inf 2002, 78 (4): 298-301. [Abstract]. Neumann M.S., Johnson W.D., Semaan S., Flores S.A., Peersman G., Hedges L.V., Sogolow E. (2002). Review and Meta-analysis of HIV Prevention Intervention Research for Heterosexual Adult Populations in the United States. JAIDS, Supplement 1, 30 (0): S106-S117. [Accès au numéro online présentant l'article complet]. Okubagzhi G., and Singh S. (2002). Etablishing an HIV/AIDS programme in developing countries: the Ethiopan experience. AIDS 2002, 16 (12) : 1575-1586. [Abstract]. Powderly W.G. (2002). Sorting through confusing messages : the art of HAART. JAIDS, 31 : S3-S9. del Rio C., Sepulveda J. (2002). AIDS in Mexico: lessons learned and implications for developing countries. AIDS, 16 (12): 1445-1457. [Abstract]. Smith T.W., Kendall P.C., Keefe F.J. (2002). Behavorial medicine and clinical health psychology: Introduction to the special issue, a view from the decade of behavior. Journal of Consulting and Clinical Psychology, 70 (3): 459-462. [Abstract]. *Sogolow E., Peersman G., Semaan S., Strouse D., Lyles C.M.(2002). The HIV/AIDS Prevention Research Synthesis Project: Scope, Methods, and Study Classification Results. JAIDS, Supplement 1, 30 (0): S15-S29.[Accès au numéro online présentant l'article complet]. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PSYCHOLOGIE
MEDICALE
|
|
|
COMMUNICATION
|
|
Barroso J. (1999). Long-term nonprogressors with HIV disease. Nursing research, Vol. 48 (5): 242-249.
Brashers D.E., Neidig J.L., Cardillo L.W.(1999). ‘In an important way, I did die’ : uncertainty and revival in persons living with HIV or AIDS. AIDS Care, Vol.11(2): 201-219.
Brashers D.E., Neidig J.L., Reynolds N.R., Haas S.M. (1998). Uncertainty in illness across the HIV/AIDS trajectory. Journal of the Association of Nurses in AIDS Care, Vol. 9 (1): 66-77.
Carricaburu D., & Pierret J. (1995). From biographical disruption to biographical reinforcement : the case of HIV-positive men. Sociology of Health & Illness, 17(1): 65-88.
Carstensen L.L., Fredrickson B.L. (1998). Influence of HIV status and age on cognitive representations of others. Health Psychology, Vol. 17 (6): 494-503.
Chapman L. (1998). Body image and HIV : implications for support and care. AIDS Care, Vol. 10, Supplement 2: S179-S189.
Charles D., Miné M., Rodriguez C. (1999). Le sida et le droit du travail. Les Editions de l’Atelier & Les Editions Ouvrières.
Chesney M.A., Folkman S. (1994). Psychological impact of HIV disease and implications for intervention. Psychiatric Clinics of North America, Vol. 17 (1): 163-182.
Chidwick A., Borrill J. (1996). Dealing with a life-threatening diagnosis : the experience of people with the human immunodeficiency virus. AIDS Care, Vol. 8 (3) : 271-284.
Crossley M.L. (1998). ‘Sick role’ or ‘empowerment’ ? The ambiguities of life with an HIV positive diagnosis. Sociology of Health & Illness, Vol. 20 (4): 507-531.
Cunningham W.E., Bozzette S.A., Hays R.D., Kanouse D.E., & Shapiro M.F. (1995). Comparison of Health-Related Quality of Life in Clinical Trial Human Immunodeficiency Virus-Infected Cohorts. Medical Care, 33(4): AS15-AS25.
Dagher E. (2000). Les séropositifs souffrent souvent d’une maladie sociale en plus de leurs problèmes de santé. Info Traitements, 82: 10-11.
Dagher E. (2000). Retour au travail des sidéens : le risque d’une mort sociale programmée. Info Traitements, 79: 1-2.
Davies M.L. (1997). Shattered assumptions : time and the experience of long-term HIV positivity. Social Science & Medicine, Vol. 44 (5): 561-571.
Delor F. (1999). Vie sexuelle des personnes atteintes, sérodiscordance et risque du sida. In: Séropositivité, vie sexuelle et risque de transmission du VIH (85-100). ANRS, Collection Sciences Sociales et Sida.
Emmanuelli J. (2000). Contribution à l'évaluation de la politique de réduction des risques : Les grandes tendances (Tome 1). Edité par l'Institut de Veille Sanitaire (St Maurice, France).
Emmanuelli J. (2000). Contribution à l'évaluation de la politique de réduction des risques : Approche détaillée à l'usage des acteurs de terrain (Tome 2). Edité par l'Institut de Veille Sanitaire (St Maurice, France).
Ezzy D., De Visser R., Grubb I., McConachy D. (1998). Employment, accommodation, finances and combination therapy : the social consequences of living with HIV/AIDS in Australia. AIDS Care, Vol. 10, Supplement 2: S189-S199.
Fabre G. (2000). VIH et Emploi à l’heure des multithérapies : les usages du secret en milieu du travail. Rapport final pour l’ANRS. Publications CNRS, 213 p.
Faucher J.M. (2000). SIDA : Guide des enjeux sociaux. Editions Espaces 34
Gilbert L., Walker L. (2002). Treading the path of leath resistance: HIV/AIDS and social inequalities-a South African case study. Social Science & Medicine, 54: 1093-1110.
Grassi L., Righi R., et al. (1999). Illness behavior, emotional stress and psychosocial factors among asymptomatic HIV-infected patients. Psychotherapy and Psychosomatics, 68: 31-38.
Hirschhorn L., Quinones J., et al. (1998). Highly active antiretroviral therapy in the « real world » : Experiences in an inner-city community health center. 12th World AIDS Conference. Geneva, June. [Abstract #32334].
Holmes W.C., & Shea JA. (1998). A New HIV/AIDS-Targeted Quality of Life (HAT-Qol) Intrument development, Reliability, and Validity. Medical Care, 36(2): 138-154.
Ironson G., Solomon G., Cruess D., Barroso J., Stivers M. (1995). Psychosocial factors related to long-term survival with HIV/AIDS. Clinical Psychology and Psychotherapy, Vol. 2 (4): 249-266.
Kressmann L. (1999). La mobilisation associative. Le Journal du Sida, Numéro Spécial Enfances & Adolescences, 120/121: 44-46.
Laurindo da Silva L. (1999). Vivre avec le SIDA en phase avancée. Paris: L'Harmattan.
Leplège A., Pouchot J., Deslandes J.Y., & Rude N. (1996). Revue des échelles de mesure de qualité de vie utilisée auprès des sujets infectés par le VIH. Revue d'Epidémiologie et de Santé Publique, 44: 23.
Maraschin J. (1999). Homoparentalité et séropositivité. Le journal du Sida, Numéro Spécial Enfances & Adolescences, 120/121: 36.
Meystre-Agustoni G. (1999). Prises de risques chez les personnes vivant avec le VIH/sida. In: Séropositivité, vie sexuelle et risque de transmission du VIH (101-112). ANRS, Collection Sciences Sociales et Sida.
Mill J.E. (2001). I'm not a "Basabasa" women. Clinical Nursing Research, Vol. 10 (3) : 254-274.
Ministère de l’Emploi et de la Solidarité (2000). Infection par le VIH/sida et travail. Paris: CFES, Collection VIH-sida.
Nieuwkerk P.T., Gisolt E.H. et al. (2000). Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. AIDS, Vol. 14 (2): 181-187.
Nolan E. Penn, et al. (1995). Ethnic minorities, Health care systems and behavior. Health Psychology, 14 (7): 641-646.
Odets W. (1995). In the shadow of the epidemic : being HIV negative in the age of AIDS. Durham: Duke University Press.
ORS Ile-de-France. (2001). Les connaissances, attitudes, croyances et comportements face au VIH/sida en Ile de France. Evolutions 1992-1994-1998-2001. Paris, ORS Ile e France, Coll. VIH/SIDA, Décembre 2001.
Pierret J. (1999). Vie sexuelle et affective des personnes asymptomatiques de longue durée. In: Séropositivité, vie sexuelle et risque de transmission du VIH (71-83). ANRS, Collection Sciences Sociales et Sida.
Prestel T. (1999). AHH* : comment bien compléter son dossier ? Remaides, 34: 34-35 [*Allocation Adulte Handicapé]
Rébillon M., Tourette-Turgis C. (1999). La prise en charge des séropositifs en grande difficulté sociale : reportage à San Francisco dans un centre expérimental sur l’observance. Info Traitements,73: 10-12.
Ross M.W., Hunter C.E. et al. (1994). The mental adjustment to HIV scale : measurement and dimensions of response to AIDS/HIV disease. AIDS Care, Vol. 6 (4): 407-411.
Rotherman-Borus M.J., Lee M.B., Gwadz M., Draimain B. (2001). An intervention for parents with AIDS and their adolescent children. American Journal of Public Health, 91 (8): 1294-1302. [abstract]
Rotheram-Borus M.J., Miller S. (1998). Secondary prevention for youths living with HIV. AIDS Care, Vol. 10(1): 17-34.
Schiltz M.A. (1999). Séropositivité, sexualité et risques. In: Séropositivité, vie sexuelle et risque de transmission du VIH (13-29). ANRS, Collection Sciences Sociales et Sida.
Schwartzberg S.S. (1993). Struggling for Meaning : How HIV-Positive Gay Men Make Sense of AIDS. Professional Psychology : Research and Practice, Vol. 24 (4): 483-490.
Simoni J.M., Mason H.R.C., Marks G. (1997). Disclosing HIV status and sexual orientation to employers. AIDS Care, Vol. 9 (5): 589-599.
Soletti J. (1999). Vous venez à AIDES, qui êtes-vous ? Remaides, 34: 16-17.
Sousa A. (1999). Couples sérodifférents et procréation médicalement assistée. Le journal du Sida, Numéro Spécial Enfances & Adolescences, 120/121: 33-35.
Swindells S., Mohr J. et al. (1999). Quality of life in patients with human immunodeficiency virus infection : impact of social support, coping style and hopelessness. International Journal of STD & AIDS, 10:383-391.
Taylor .ER., Amodei N., Mangos R. (1996). The presence of psychiartic disorders in HIV-infected women. Journal of Counseling & Development, Vol.74: 345-351.
Tourette-Turgis C., Pereira-Paulo L., Rébillon M. (2002). Coopération Nord/Sud - L'arrivée des antirétroviraux: une économie sociale et familiale pertubée, une confrontation à d'impossibles dilemmes. Le Journal de la Démocratie sanitaire, 146: 24-28. [pdf]
Tourette-Turgis C. (2000). De la promesse thérapeutique à la promesse sociale. Info Traitements, 85: 11-12.
Trussler T., Marchand R. (1997). Veiller les uns sur les autres - Guide d'action communautaire - Promotion de la la santé VIH : Théorie, Méthode et Pratique. Vancounver: AIDS Vancouver.
Vosvick M., Gore-Felton C., Koopman C., Thoresen C., Krumboltz J., Spiegel D. (2002). Maladaptive coping strategies in relation to Quality of Life mong HIV+ adults. AIDS and Behavior, 6 (1) : 97-106.
AIDES Fédération Nationale (1999). Les mille et une façon de prendre son traitement. Document du 2 avril 1999.
AIDES Fédération Nationale (1999). Vie quotidienne et traitements de l’infection à VIH. Enquête AIDES/IPSOS, Document du 2 avril 1999.
Anderson R. (2001). A guide to the clinical care of women with HIV/AIDS. U.S. Department of Health and Human Services, Health Resources and Services Administration. (2001, First edition).
Aversa S.L., Kimberlin C., Segal R. (1998). The medication attribution scale : perceived effects of antiretrovirals and quality of life. Quality of Life Research, Vol. 7: 205-213.
Aversa S.L., Kimberlin C. (1996). Psychosocial aspects of antiretroviral medication use among HIV patients. Patient Education and Counseling, 29: 207-219.
Bangsberg D.R., Tulsky J.P., Hecht F.M. et al.. (1997). Protease inhibitors in the homeless. J. of the Amrican Medical Association, 278: 63-65.
Casado A., Consiglio E., Podzamcze D., Badia X. (2001). Highly Active Antiretroviral Treatment (HAART) and health-related quality of life in naive and pretreated HIV-infected patients. HIV Clinical Trials, 2(6): 477-483. [Full Text]
Colebunders R., Schrooten W., Dreezen C., Baratta C., et al. (2001). Antiretroviral treatments used among adults with HIV infection in Europe. AIDS Care, Vol. 13 (1): 5-14
Delfraissy J.F. (2000). (sous la direction de). Rapport sur la prise en charge thérapeutique des personnes infectées par le VIH. [Actualisation du Rapport 1999 - Document accessible sur le site du Ministère délégué à la santé: http://www.sante.gouv.fr/htm/actu/rap_delf/index_delfra00.htm ]
Delfraissy J.F. (1999). (sous la direction de). Prise en charge thérapeutique des personnes infectées par le VIH - Rapport 1999, Recommandations du groupe d'experts. Paris: Médecine-Sciences Flammarion. [Document accessible sur le site du Ministère délégué à la santé:] http://www.sante.gouv.fr/htm/dossiers/sidahop/index_delfra.htm
DiClementi R.J., Funkhouser E., Wingood G., Fawal H., Holmberg S.D., Vermund S.H. (2002). Protease inhibitor combination therapy and decreased condom use among gay men. South Med J., 95(4): 421-425 [Abstract]
Duran S., Saves M., Spire B., Cailleton V., Sobel A., Carrieri P., Salmon D., Moatti J.P., Leport C., The APROCO Study Group. (2001). Failure to maintain long-term adherence to highly active antiretroviral therapy : the role of lipodystrophy. AIDS, 15 (18): 2441-2444. [Abstract]
Farber E.W., McDaniel S. (1999). Assessment and psychotherapy practice implications of new combination antiviral therapies for HIV disease. Professional Psychology: Research and Practice, 30 (2): 173-179.
Flaskerud J.H. (1995). HIV/AIDS : a guide to nursing care. Philadelphia: W.B. Saunders, 405-432.
Folkman S., Chesney M.A. (1995). Coping with HIV Infection. In: M. Stein, P. Baum (Eds.), Chronic diseases: Perspectives in behavorial medicine (115-133), Mahwah, NJ: Erlbaum.
Gerber B., Love C., Caspers N. et al. (1999). « Making all the difference in the world : How physicians can help HIV-seropositive patients become more involved in their healtcare. AIDS Patient Care and STDs, Vol. 13 (1): 29-39.
Gilden D. (1999). Protease inhibitors, sexual dysfunction and Viagra. Treatment Issues, Vol. 13 (3): 12.
Grabar S., Pradier C., Le Corfec E. et al. (2000). Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor. AIDS, Vol. 14(2): 141-149.
Justice A.C., Holmes W., Gifford A.L. et al. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54: S77-S90.
Lenderking W.R., Gelber R.D. et al. (1994). Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The New England Journal of Medicine, Vol. 330 (11): 739-743.
Lin M.K., Wu A.W., Revicki D.A. (2002). Incorporating quality of life measures in HIV clinical trials. HIV Clinical Trials, 3(3): 202-218. [Full Text]
Lori F., Lisziewicz J. (2001). Structured treatment interruptions for the management of HIV infection. JAMA, Vol. 286: 2981-2987 [Abstract], [Full Text]
Malafronte B., Perbost I., Dunais B., et al. (1999). Unconventional medicine and AIDS : Trends in behavior among patients receiving protesase inhibitors. 12th World AIDS Conference. Geneva, June. [Abstract #14119].
Malsan S. (2002). Les tradipraticiens, un réel espoir pour l'Afrique. Le Journal de la Démocratie sanitaire, N° 142 : 30-32.
March F., Garriga X., Rodriguez P., Moreno C., Garrigo M., Coll P., & Prats G. (1997). Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis. Clinical Infectious Diseases, 25 (5): 1044-7.
Mathews W.C., Mar-Tang M., Ballard C., Colwell B., Abulhoso K., Noonan C., Barber R.E., Wall T.L. (2002). Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy. AIDS Patients Care STDS, 16 (4): 157-172. [Abstract]
Morgenstern T.T., Grimes D.E., Grimes R.M. (2002). Assessment of readiness to initiate antiretroviral therapy. HIV Clinical Trials, 3 (2): 168-172. [Full Text]
Msellati P., Vidal L., Moatti J.P. (sous la direction) (2001). L'accès aux traitements du VIH/SIDA en Côte d'Ivoire. Paris : ANRS, Coll. Sciences Sociales et Sida.
Meystre-Agustoni G., Dubois-Arber F. Cochand P. & Telenti A. (2000). Antiretroviral therapies from the patient's perspective. AIDS Care, Vol.12 (6): 717-721
Ministère de l’Emploi et de la Solidarité (1999). Traitement de l’infection à VIH. Antirétroviraux : prescription, dispensation et prise en charge. Paris: CFES, Collection VIH-sida, 2ème édition.
Ministère de l’Emploi et de la Solidarité (1999). Guide pratique des antirétroviraux - " Prendre un médicament c’est toute une histoire". Paris: CFES, Collection VIH-sida, 2ème édition.
Morin M. (2001). Croyances, attitudes et représentations sociales dans la prévention et le traitement de l'infection au VIH. In: M.L. Bruchon-Schweitzer, B. Quintard (Eds.), Personnalité et maladie (239-258), Paris: Dunod.
Moyle G.J., Gazzard B.G. (1999). A risk-benefit assessment of HIV protease inhibitors. Drug Safety, Vol. 20 (4): 299-321.
Peytavin G., Certain A., Rebillon M. (1999). Dosages : ajuster le traitement pour chaque patient. Info Traitements, Numéro Spécial Observance, 64/65: 14-17.
*Powderly W.G. (2002). Sorting through confusing messages : the art of HAART. JAIDS, 31 : S3-S9.
Royer E.S., Weibel N., Bonin B., Dobracheff C., Laurent R. (2000). Vers un meilleur vécu des traitements. Le Journal du Sida, 123: 13-14.
Tourette-Turgis C., Rébillon M. (2001). Infection par le VIH - Accompagnement et suivi des personnes sous traitement antirétroviral. Paris: Comment Dire.
Tourette-Turgis C. (2000). De la promesse thérapeutique à la promesse sociale. Info Traitements, 85: 11-12.
Trénado E., Prestel T. (1999). Peut-on interrompre son traitement anti-VIH ? Remaides, 34: 28-29.
Treisman G.J., Angelino A.F., Hutton H.E. (2001). Psychiatric issues in the management of patients with HIV infection. JAMA, 286 (22): 2857-2864.
Tuomala R.E., Shapiro D.E., Mofenson L.M., Bryson Y., Culnane M., Hughes M.D., O'Sullivan M.J., Scott G., Stek A.M., Wara D., Bulterys M. (2002). Antiretroviral therapy during pregnancy and the risk of an adverse outcome. The New England Journal of Medecine, 346 (24): 1863-1870. [Abstract]
Vosvick M., Gore-Felton C., Koopman C., Thoresen C., Krumboltz J., Spiegel D. (2002). Maladaptive coping strategies in relation to Quality of Life mong HIV+ adults. AIDS and Behavior, 6 (1) : 97-106.
OBSERVANCE TRAITEMENTS CONTRE LE VIH/sida
American Psychological Association. (1997). Adherence to HIV/AIDS drug therapy. Testimony of the American Psychological Association submitted to the United States Senate – Committee on Labor and Human Resources, October 30. http://www.apa.org
"Adherence to HIV/AIDS Drug therapy", Testimony of The American Psychological Association submitted to the United States Senate Committee on Labor and Human Resources, Octobre 30, 1997
Altice FL., Mostashari F., Thompson AS., et al. (1997). Perceptions, acceptance and adherence to antiretrovirals among prisoners. Proceedings of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, Jan. 22-26, 1997. Abstract #253.
Arras JD. (1990). Non compliance in Aids Research. Hastings center report, 20(5): 24-32.
Aversa SL., Kimberli C. (1996). Psychosocial aspects of antiretroviral medication use among HIV patients. Patient Education and Counseling, 29: 207-219.
Bachiller P., Arrando FR., Liceaga G., et al. (1998). Adherence to antiretroviral therapy in HIV-infected persons. 12th World AIDS Conference. Geneva, June. [abstract #32392].
Bailey A., et al. (1995). Factors affecting an individuals ability to administer medication. Home Healthcare Nurse, 13 (5): 57-63.
Bamberger JD. (1999). Novel HIV Medication Adherence Support Program in San Francisco. Draft du 22 septembre (non publié – 5 p.).
Bangsberg DR., Hecht FM., Charlebois ED., et al.. (2000). Adherence to protease inhitors, HIV-1 load, and development of drug resistance in an indigent population. AIDS, 14: 357-366.
Bangsberg DR., Moss A. (1999). When should we delay highly active antiretroviral therapy? J Gen Intern Med, 14: 446-448.
Bangsberg DR., Zolopa AR., Charlebois E., et al. (1998). HIV-infected homeless and marginally housed (H/M) patients adhere to and receive early virologic benefit from protease inhibitors (PI). Proceedings of the 5th Conference on Retroviruses and Opportunistic Infections, Chicago, I11, Feb. 1-5, 1998. Abstract #152.
Baron B., Tourette-Turgis C., Rebillon M. (1999). Monitoring électronique de l'adhésion à un traitement VIH par antirétroviral dispensé dans une pharmacie de ville. [diapositives] Présentation des résultats d'une étude sur le suivi d'observance en pharmacie de ville, Novembre 1999.
Baylac M., Guessant S., Tabti K., Cousin P. (2000). Un modèle de feuille "conseil aux patients" pour la prise des antirétroviraux. Journal de Pharmacie Clinique, 19(3): 223-229.
Becker M.H., Maiman L.A. (1980). Strategies for enhancing patient compliance. Journal of Community Health, 6: 113-115.
Becker, et al. (1978). Compliance with a Medical Regimen for Asthma. Public Health Reports, 93: 268-277.
Becker M.H., & Maiman LA. (1975). Sociobehavioral Determinants of compliance with Health and Medical care. Medical Care, 13 (1): 10-24.Beechem M.H. (1995). Developing a culturally-sensitive treatment : plan in pre-hospice South Texas. Hospice Journal, 10 (2): 19-34.
Bentz L., Pradier C., Tourette-Turgis C., Morin M., Rébillon M. et al. (2001). Description et évaluation d'un programme d'intervention sur l'observance thérapeutique (counseling) dans un centre hospitalo-universitaire. In : Ed. ANRS : L'observance aux traitements contre le VIH : Mesure, déterminants, évolution. Collection Sciences Sociales et Sida, Décembre 2001: 99-112.
Bentz L., Pradier C., Tourette-Turgis C., Rébillon M., Morin M., et al.. (2001). Impact of a counseling program on treatment adherence in HIV infected persons treated by HAART in a French University Hospital. Fifth International Conference AIDS IMPACT 2001, Biopsychosocial aspects of HIV infection, Brighton, United Kingdom, July 8-11, 2001. (Oral presentation, July 9). [diapos en anglais]
Besch C.L. (1995). Compliance in clinical trials. AIDS, 9 (1): 1-10.
Bessette D., Rebillon M. (1999). La direction Générale de la Santé et l’observance – Définir des recommandations applicables. Info Traitements, Numéro Spécial Observance, 64/65 : 25-26.
Blumenfield M., Milazzo J., Wormser GP. (1990). Noncompliance in hospitalized patients with AIDS. General Hospital Psychiatry, 12: 166-169.
Bogart L.M., Catz S.L., Kelly, J.A., et al. (2001). Factors influencing physicians'judgments of adherence and treatment decisions for patients with HIV disease, Med. Decis Making, 21(1): 28-36.
Boitel-Stein R., Tourette-Turgis C. (1999). Libérer la parole sur les traitements : parler des effets secondaires et des problèmes d’observance dans un groupe de personnes en trithérapie. Info Traitements, Numéro Spécial Observance, 64/65: 31-32.
Bond N.S., et al. (1991). Detection methods and strategies for improving medication compliance. AJPH, 48: 1978-1998.
Botello J., Dudrak R. (1992). Home assessment of adherence to long-term medication in the elderly. J Fam Pract, 35: 61-65.
Brandimonte M.A et Passolunghi M.A (1994). The effect of cue-familiarity, cue-distinctiveness, and retention interval on prospective remembering. Quaterly Journal of Experimental Psychology, 47 A(3) : 566-587.
Breton C., Tourette-Turgis C. (1999). Docteur, j’adhère au traitement… mais j’oublie. Info Traitements, Numéro Spécial Observance, 64/65 : 20-21.
Brigido L.F., Veiga A.P., et al. (1998). Low adherence in antiretroviral users at Sao Paolo, Brazil. 12th World AIDS Conference. Geneva, June. [Abstract #32370].
Broers B, Morabia A, et al. (1998). A Cohort Study of Drug Users' Compliance with Zidovudine Treatment. Arch Intern Med, 154(10):1121-7.
Brown C.M. (1998). Use of alternative therapies and their impact on compliance : Perceptions of community pharmacists in Texas. Journal of the American Pharmaceutical Association, Vol. 38 (5) :603-607.
Brown M.A., Inouye J., Powell-Cope G.M. et al. (1998). Social support and adherence in HIV+ persons. 12th World AIDS Conference. Geneva, June. [Abstract #32346].
Burgos M., Revsin N.S. et al. (1998). Obstacles in treatment adherence : Patients reasons. 12th World AIDS Conference. Geneva, June. [Abstract #32400].
Celentano D.D., Vlahov D., Cohn S., et al. (1998). Self-reported antiretroviral therapy in injection drug users. JAMA, August 12, 280 (6): 545-546.
Cheever L.W. (2001). Adherence to HIV therapies. In : A guide to the clinical care of women with HIV/AIDS, (139-148), U.S. Department of Health and Human Services, Health Resources and Services Administration (2001, First Edition).
Cheever L.W., Kervly J.C., Moore R.D. (1999). Antiretroviral use and adherence predicted by active illicit drug use. 39th Interscience Conference on Antimicrobial Agents and Chemotheray. San Francisco, September. [Abstract #596].
Cherabi K., Tourette-Turgis C. (1999). Suivre des personnes en grande difficulté sociale. Infos Traitements, Numéro Spécial Observance, 64/65: 33-34.
Chesney M.A., Morin M., Sherr L. (2000). Adherence to HIV combination therapy. Soc. Sci. Med., 50(11): 1599-1605.
Chesney M.A., Ickovics J.R., Chambers D.B. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials : the AACTG adherence instruments. AIDS Care, Vol. 12 (3): 255-266.
Chesney M.A., Ickovics J., Hecht F.M., et al. (1999). Adherence: a necessity for successful HIVcombination therapy. AIDS, 13: S271-S278.
Chesney M.A., Tourette-Turgis C. (1999). Partenariat médecin/patient : gérer soi-même son traitement. Info Traitements, Numéro Spécial Observance, 64/65: 12-13.
Chesney M.A. (1997). Compliance : how you can help. HIV Newsline, 4(3): 67-72
Chesney M.A., Folkman S., Chambers D. (1996). Coping effectiveness training for men living with HIV : preliminary findings. International Journal of STD & AIDS, 7 (Suppl. 2): 75-82
Chesney M.A., Folkman S. (1994) "Psychological impact of HIV disease and implications for intervention", Psychiatric Clinics of North America, 17 (1): 163-182.
Chow R., Chin T., Fong I.W., Bendayan R. (1993). Medication use patterns in HIV-positive patients. Canadian Journal of Hospital Pharmacy, 46 (4): 171-175
Cook R.L., Sereika S.M., Woodward W.C., et. al. (2001). Problem drinking and medication adherence among persons with HIV infection. J. Gen.Intern. Med., 16( 2): 83-88.
Corless I.B., Holzemer W.L., Turner J.G., et al. (1998). Cognition and HIV adherence. Proceedings of the 12th World AIDS Conference, Geneva, Switzerland, June 28-July 3, 1998. Abstract #32387.
Costagliola D. Barberousse C. (2001). Comment mesurer l'observance ? In : Ed. ANRS : L'observance aux traitements contre le VIH : Mesure, déterminants, évolution. Collection Sciences Sociales et Sida, Décembre 2001: 33-42.
Courpotin C., Rebillon M. (1999). Gérer le refus du traitement chez l’enfant. Info Traitements, Numéro Spécial Observance, 64/65 : 28-29.
Courpotin C. (1999). Echappement thérapeutique chez des patients adolescents. Action, 63: 10-11.
Crespo-Fierro M. (1997). Compliance/Adherence and Care management in HIV Disease. Journal of the Association of Nurses in AIDS Care, Vol. 8 (4), July-august, 43-54.
Davis M.S. (1966). Variations in patients' Compliance with Doctors' Orders : Analysis of Congruence between Survey Responses and Results of Empirical Investigations. Journal of Medical Education, 41 (11): 1037-1048.
Davis M.S. (1968). Physiological, Psychological and Demographic Factors : Patient Compliance with Doctors' orders. Medical Care, 6: 115-122.
Demas P., et al. (1998). The relationship between HIV treatment acceptance and adherence to psychosocial factors among injecting drug users. AIDS and Behavior, 2 (4): 283-292.
Desclaux A. (2001). L'observance en Afrique : question de culture ou "vieux problème" de santé publique ? In : Ed. ANRS : L'observance aux traitements contre le VIH : Mesure, déterminants, évolution. Collection Sciences Sociales et Sida, Décembre 2001: 57-66.
DiMatteo M.R., Sherboune C.D., Hays R.D., et al. (1993). Physicians'characteristics influence patients'adherence to medical treatment: Results from the medical outcomes study. Health Psychology, 12: 93-102.
Donovan J.L., Blake D.R. (1992). Patient non-compliance: deviance or reasoned decision-making? Soc. Sci. Med., 34: 507-513.
Dunbar-Jacob J. (1990). Predictors of patient adherence : patient characteristics. In: Shumaker SA, Shron E, Ockene JK et al. (Eds.), The Handbook of health behavior change (348-359). New York: Springer Publishing Co.
Dunbar-Jacob J., Burke L.E., Puczynski S. (1990). Clinical assessment and management of adherence to medical regimens. In: S.A. Shumaker, E. Shron, J.K. Ockene, et al. (Eds.). The Handbook of health behavior change (313-339). New York: Springer Publishing Co.
Dunbar-Jacob J., Dwyer K., Dunning E.J. (1991). Compliance with anti-hypertension regimen : A review of the research in the 1980s. Annals of Behavorial Medicine, 13, 31-39.
Dunbar J.M., & Stunkard A.J. (1979). Adherence to diet and drug regimen. In: R. Levy, B. Rifking, B. Dennis, et al. (Eds.), Nutrition, Lipids and Coronary Heart Disease (391-423), New York: Raven Press.
Duran S., Saves M., Spire B., Cailleton V., Sobel A., Carrieri P., Salmon D., Moatti J.P., Leport C., The APROCO Study Group. (2001). Failure to maintain long-term adherence to highly active antiretroviral therapy : the role of lipodystrophy. AIDS, 15 (18): 2441-2444. [Abstract]
Duran S., Spire B., Raffi F., et al. (2001). Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clinical Trials, 2(1): 38-45 [Abstract]
Eldred L., Wu A., Chaisson R.E., et al. (1997). Adherence to antiretroviral therapy in HIV disease. Proceedings of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, Jan. 22-26, Abstract #251.
El-Sadr W., Medard F., Barthaud V. (1993). Directly observed therapy for tuberculosis: The Harlem Hospital experience. American Journal of Public Health, 86: 1146-1149.
Eraker S.A., Kirst J.P., Becker M. H. (1984). Understanding and improving patient compliance. Annals of International Medecine, 100: 258-268.
Escaffre N., Morin M., Bouhnik. A.D. (2000). Injecting drug users'adherence to HIV antiretroviral treatments: physicians'beliefs. AIDS Care, 12 (6): 723-730.
Faure J. (1998). Les programmes d'aide à l'observance : Premier bilan. Le Journal du Sida,105-106: 20-23.
Fogarty L., Roter D., Larson S., Burke J., Gillespie J., Levy R. (2002). Patient adherence to HIV medication regimens: a review of published and abstracts reports. Patient Education and Counseling, 46 (2) : 93-108. [abstract]
Folkman, S., Chesney, M.A. (1995). Coping with HIV Infection. In : M. Stein and A. Baum (Eds.), Perspectives on Behavioral Medicine. Hillsdale, NJ: Erlbaum, 115-134.
Ford P.M., Carson R., Pepperell S. (1998) Drug compliance in patients starting saquinavir. 12th World AIDS Conference. Geneva, June. [abstract #60151]
Forum for Collaborative HIV Research (1999). Adherence to HIV Therapy : building a bridge to success. Report from a Workshop, Washington, DC. November 15-16.
Fourney A. (2000). Formative evaluation of an intervention to increase adherence to HIV/AIDS therapies among low-literacy populations. HIV/AIDS Conference. Durban (South Africa), Juillet 2000. [abstract # ThPeB5007].
Freeman R.C., Rodriguez G.M., French J.F. (1996). Compliance with AZT treatment regimen of HIV-seropositive injection drug users: A neglected issue. AIDS Education and Prevention, 8 (1): 58-71.
Frick P.A., Gal P., Lane T.W., et al. (1998). Antiretroviral medication compliance in patients with AIDS. AIDS Patient Care and STDs, 12, 463-470.
Friedland G.H. (1997). Adherence : The Achilles heel of highly active antiretroviral therapy : Improving the management of HIV disease. International AIDS Society-USA, 5: 13-15
Galland J., Block D., (1998). Adherence to antiretroviral regimens in HIV-infected patients: results of a survey among patients and physicians. J Int Assoc Physicians AIDS Care, Vol. 4: 32-35.
Gao X., Nau D. P. , Rosenbluth S.A., Scott V. & Woodward C. (2000). The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care, Vol. 12 (4): 387-398.
Garrity T.F. (1981). Medical compliance and the clinician-patient relationship : a review. Social Science & Medicine, Vol. 15E : 215-222.
Gifford A.L., Bormann J.E., Shively M.J. et al. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23: 386-395.
Gifford A.L., Shively M.J., Bormann D., et al. (1998). Self-reported adherence to combination antiretroviral medication (ARV) regimens in a community-based sample of HIV-infected adults. Proceedings of the 12th World AIDS Conference, Geneva, Switzerland, June 28-July 3, 1998. Abstract #32338.
Gir E., Pratt R., Bunch E.H, Holzemer W.L. (1998). Adherence to antiretroviral therapy : A jour country comparaison. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3 [Abstract #60129]
Goodwin D.L., Insull W., Jr, Russel M.L., Probstfield J.L. (1990). Predicting adherence to prescribed regimens using the health perceptions questionnaire (HPQ). In: S.A. Shumaker, E. Shron, J.K. Ockene, et al. (Eds.), The Handbook of health behavior change (64-83), New York: Springer Publishing Co.
Gordillo V., del Amo J., Soriano V., Gonzalez-Lahoz J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13 : 1763-1769.
Gordillo V., Fernandez R., Ramiro B. et al. (1998). Towards a new approach for the assessment of adherence to therapy. Proceedings of the 12th World AIDS Conference, Geneva, Switzerland, June 28-July 3. [Abstract #32382].
Guessant S. (1999). Regularité des prises et contraintes associées : un plan personnalisé de prises des médicaments proposé à la pharmacie de l’hôpital Rothschild. Info Traitements, 64/65 : 35-36
Halkitis P.N. (1999). The Seropositive Urban Drug Injectors’ Study Team. Access to antiretroviral treatment and adherence to treatment in injecting drug users and men who have sex with men. National HIV Prevention Conference. Atlanta, USA, August. [Abstract #336].
Halkitis P.N. (1998). Advances in the treatment of HIV disease : Complexities of adherence and complications for prevention. Health Psychologist, 20 (1): 6-7,14.
Hartman P.E., Becker M.H. (1978). Noncompliance with Prescribed Regimen among Chronic Hemodialysis Patients : A method of Prediction and Educational Diagnosis. Dialysis and Transplantation, 978-989.
Haynes R.B. (1976). A critical review of the " determinants " of patient compliance with therapeitic regimens. In: D.L. Sackett, R.B. Haynes (Eds.), Compliance with therapeutic regimens (26-39), Baltimore: John Hopkins University Press.
Haynes R.B. (1979). Introduction. In R.B: Haynes, D.W. Taylor & D.L. Sackett (Eds.), Compliance in Health Care, i-15, Baltimore: John Hopkins University Press.
Haynes R.B., Mattson ME., Engebretson TO. (Eds.) (1980). Patient compliance to prescribed antihypertensive medication regimens: A report to the national heart, lung, and blood institute. Bethesda, MD: DHHS (NIH Publication, No 81-2102).
Haynes R.B., McKibbon KA., Kanani R. (1996). Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet, 348: 383-386
Haynes R.B. (1979). Determinants of Compliance : The Disease and the Mechanics of Treatment. In: R. B. Haynes, D.W. Taylor, & D. L. Sackett (Eds.), Compliance en Health Care (46-62), Baltimore: Johns Hopkins University Press.
Haubrich R.H., Little S.J. Currier J.S., et al. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS, 13: 1099-1107.
Hefez S. (sous la direction de), (1996). Sida et Vie Psychique - Approche clinique et prise en charge. Paris: La Découverte (préface de Jonathan Mann).
Holzemer W.L., Inouye J., Brown M.A. et al. (1998). Psychological well-being and HIV adherence. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32368].
Homedes N., Ugalde A. (2001). Improving the use of pharmaceuticals through patient and community level interventions. Soc. Sci. Med., 52(1): 99-134.
Horne R., Pearson S., Leake H. et al. (1999). Patients’belief about HAART influence adherence to antiretroviral therapy. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, September. [Abstract #588].
Horne R. (1998). Adherence to medication: a review of existing research. In: L Myers, K.Midence (Eds), Adherence to Treatment in Medical Conditions (285-310), Buffalo, NY: Hardwood.
Horwitz R.I., Horwitz S.M. (1993). Adherence to treatment and health outcomes. Archives of Internal Medicine, 153: 1863-1868.
*Hugen P.W.H., Langebeek N., Burger D.M., Zomer B., van Leusen R. et al. (2002). Assessment of Adherence to HIV Protease Inhibitors: Comparison and Combination of Various Methods, Including MEMS (Electronic Monitoring), Patient and Nurse Report, and Therapeutic Drug Monitoring. JAIDS, 30 (3): 324-334. [Abstract].
Ickovics J.R., Meisler A.W. (1997). Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J. Clin Epidemiol, 50 (4): 385-391
Johnston B.E., Ahmad K., et al. (1998). Adherence to HAART among HIV-infected patients of the inner city. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32389].
Jones A.M., Thaker H., Foley B. et al. (1998). A qualitative study on retroviral therapy : Drug compliance in IVDU patients. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32361].
Jones J.L., Nakashima A.K., Kaplan J.E. (1999). Adherence to primary prophylaxis for pneumocystis carinii pneumonia : Results from a multi-state interview project. 39th Interscience Conference an Antimicrobial Agents and Chemotherapy. San Francisco, September. [Abstract #586].
Kammann E., Williams P., Chesney M.A., Currier J. (1999). Predictors of adherence to arithromycin prophylaxis for prevention of mycobacterium avium complex (MAC) disease. 6th Conference on Retroviruses and Opportunisctic Infections. Chicago, January. [Abstract #444].
Kaplin A., Golin C., Beck K. et al. (1999). Adherence to protease onhibitor therapy and viral load. 6th Conference on Retroviruses and Opportunistic Infections. Chicago. January [Abstract #96].
Kastrissios H., Suarez J.R., Hammer S., et al. (1998). The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [abstract #32392].
Kemppainen J.K., Levine R.E., Mistal M. & Schmidgall D. (2001). HAART adherence in culturally diverse patients with HIV/AIDS: A study of male patients from a veteran's administration hospital in Nothern California. AIDS Patient Care and STDs, Vol. 15 (3): 117-127.
Kim H.M., Lagakos S.W. (1994). Assessing drug compliance using longitudinal marker data with application to AIDS. Statistics in Medicine, 141: 2153
Kirscht J.P., Rosenstock I.M. (1977). Patient Adherence to Antihypertensive Medical regimens. Journal of Community Health, 3: 115-124.
Kirstetter M., Rebillon M. (1999). Informer avant de traiter. Info Traitements, Numéro Spécial Observance, 64/65: 30.
Kissinger P., Cohen D., Brandon W., Rice J., Morse A., Clark R. (1995). Compliance with public sector HIV medical care. Journal of the National Medical Association, 87: 19-24.
Klaus B.D., et al. (1997). Assessing and enhancing compliance with antiretroviral therapy. Nurse Pract ., 22 (4): 211-219.
Klosinski L.E., Brooks R.N. (1998). Predictors of non-adherence to HIV combination therapies. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32375].
Kosko D., Neff-Smith M., Kim. M. (1998). Adherence barriers to complex antiretroviral regimen: the perceptions of HIV+ women and nurses. Proceedings of the 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3, 1998. [Abstract #65/32352].
Kruse W., Rampmaier J., Ullrich G., Weber E. (1994). Patterns of drug compliance with medication to be taken once and twice daily assessed by continuous electronic monitoring in primary care. International Journal Clinical Pharmacology Therapy, 32: 453-457
Kunches L., Mazzullo J.M., et al. (1998). Educational and support needs of people living with HIV to improve adherence to HAART. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32333].
La Greca A. (1990). Issues in adherence with pediatric regimens. Journal of pediatrics psychology, 15 (4): 423-436.
Laine C., Newschaffer C.J., Zhang D., et al. (2000). Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstetrics & Gynecology, 95 (2): 167-173.
Le Coz S., Rébillon M., Tourette-Turgis C., et al. (1998). Counseling PWAs on adherence issues. 12th international conference on AIDS. Geneva, Switzerland, June 28-July 3. [Abstract 24330].
Lerner B.H., Gulick R.M., Dubler N.N. (1998). Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV-disease. Ann Intern Med, 129: 573-578.
Leventhal H. (1993). Compliance : Theories of compliance and turning necessities into preferences : Application of adolescent health action. In: N.A. Krasnegor, L.H. Epstein, S. Bennett Johnson, S.J. Yaffe (Eds.), Developmental aspects of health compliance behavior (91-124), Hillsdale, N.J: Erlbaum.
Leventhal H., Zimmerman R., Gutmann M. (1984). Compliance : A self-regulatory perspective. In: W.D. Gentry (Ed.), Handbook of behavorial medicine (369-436), New York: Guilford
Ley P. (1981). Professional non-compliance: neglected problem. British Journal of Clinical Psychology, 20: 151-154
Lopez-Suarez A., Fernandez-Gutierrez del Amo C., et al. (1998). Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients. AIDS, 12: 685-686.
Marlatt G.A., Georges W.H. (1990). Relapse prevention and maintenance of optimal health. In: S.A. Shumaker, E. Shron, J.K. Ockene et al. (Eds.), The Handbook of health behavior change (44-63), New York: Springer Publishing Co.
Marlatt G.A., Gordon J.R. (1980). Determinants of relapse: Implications for the maintenance of behavior change. In : Davidson P.O., Davidson S.M. (Eds.), Behavioral medicine: Changing health lifestyles (410-452), New York: Brunner/Mazel.
Marston M.-V. (1970). Compliance with Medical Regimens : A Review of the Literature. Nursing Research, 19(4): 312-323.
Martin J., Escobar I., Rubio R. et al. (2001). Study of the validity of a questionnaire to assess the adherence to therapy in patients infected by HIV. HIV Clinical Trials, 2 (1):31-37
Mathews W.C., Mar-Tang M., Ballard C., Colwell B., Abulhoso K., Noonan C., Barber R.E., Wall T.L. (2002). Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy. AIDS Patients Care STDS, 16 (4): 157-172. [Abstract]
Mehta S., Moore R, Graham M.M.H. (1997). Potential factors affecting adherence with HIV therapy, AIDS, 11: 1663- 1670.
Meichenbaum D., Turk D. (1987). Facilitating Treatment Adherence: A Practitioner's Guidebook. New York: Plenum Press.
Messica F. (1999). Vie sociale et observance des traitements. Le Journal du Sida, Numéro Spécial Enfances & Adolescences, 120/12 : 16-18.
Meyer D., Leventhal H., Gutmann M. (1985). Common-sense models of illness : The example of hypertension. Health Psych, 4: 115-135.
Meystre-Agustoni G., Dubois-Arber F. Cochand P. & Telenti A. (2000). Antiretroviral therapies from the patient's perspective. AIDS Care, Vol. 12 (6): 717-721
Miller L., Lui H., Beck K. et al. (1999). Providers estimates of adherence overestimate reports from medication event monitoring system (MEMS) for patients on protease inhibitors. 6th Conference on Retroviruses and Opportunistic Infections. Chicago, January [abstract # 97].
Miller N.H., Hill M., Kottke T., et al. (1997). The multilevel compliance challenge: Recommendations for a call to action. Circulation, 95: 1085-1090.
Ministère de l’Emploi et de la Solidarité (1999). Accompagnement des personnes atteintes par l’infection à VIH. Pour une meilleure adhésion aux traitements antirétroviraux. Paris: CFES, Collection VIH-sida
Mitty J.A., Stone V.E., Sands M., Macalino G. and Flanigan T. (2002). Directly Observed Therapy for the treatment of people with human immunodeficiency virus infection: A work in progress. Clinical Infectious Disease, 34: 984-990. [Abstract]
Moatti J.P., Spire B.(2000). Living with HIV /AIDS and adherence to antiretroviral treatments. In : Moatti et al. (Eds.), AIDS in Europ, new challenges for the social sciences (57-73), London: Routledge.
Moatti J.P., Carrieri M.P., Spire B. et al. (2000). Adherence to HAART in French HIV-infected injecting drug users : the contribution of buprenorphine drug maintenance treatment. AIDS, Vol. 14 (2): 151-155.
Moatti J.P., Spire B. (2000). Au-delà de l’observance - Les recherches socio-comportementales sur l’impact des multithérapies antirétrovirales. Transcriptase, 83: 21-25.
Moatti J.P., Spire B., Duran S. (2000). Un bilan des recherches socio-comportementales sur l’observance des traitements dans l’infection à VIH : au-delà des modèles biomédicaux ? Revue Epidémiologique et Santé Publique, 48: 182-197.
Moatti J.P., Morin M. (1993). L'adhérence des patients : un défi aux protocoles. Le Journal du SIDA, 54-55: 20-23.
Moralez R., Figueiredo V.M., Sinkoc M.C.B. et al.. (1998). Adherence of patients with AIDS to treatment with antiretroviral medications : Difficulties related and proposition of attenuating measures. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [abstract #42442].
Morgenstern T.T., Grimes D.E., Grimes R.M. (2002). Assessment of readiness to initiate antiretroviral therapy. HIV Clinical Trials, 3 (2): 168-172. [Full Text]
Morin M. (2001). De la recherche à l'intervention sur l'observance thérapeutique : contributions et prespectives des sciences sociales. In : Ed. ANRS : L'observance aux traitements contre le VIH : Mesure, déterminants, évolution. Collection Sciences Sociales et Sida, Décembre 2001: 5-20.
Morin M. (1998b). Prise en charge thérapeutique du SIDA et observance. Bulletin de l'ANRS, 24: 49-52.
Morin M., Moatti J.P. (1998). Observance et essais thérapeutiques : obstacle psychosociaux dans la recherche sur le traitement de l'infection par le VIH. Natures Sciences Sociétés, 4 (3): 228-240.
Morin M., Souville M., & Moatti J.P. (1997). L'observance des traitements antirétroviraux. In: 40e Journées de l'Hôpital Claude BERNARD - Actualité des Traitements Antirétroviraux (101-105), Paris: EDK.
Morse E.V., Simon P.M., Coburn M., et al. (1991). Determinants of Subject Compliance within an Experimental Anti-HIV Drug Protocol. Social Science and Medicine, 32(10): 1161-1167.
Morse E.V., Simon P.M., Besch C.L., Walker J. (1995). Issues of recruitement, retention and compliance in community-based clinical trials with traditionally unserserved populations. Applied Nursing Research, 8 (1): 8-14.
Mostashari F., Riley E., Selwyn P.A., Altice R.L. (1998). Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. J. Acquir Immune Defic Synd Hum Retroviral, 18: 341-348
Moulin P. (2001). Enquête sur les pratiques des professionnels de santé en matière d'observance dans le domaine du VIH/sida en France : Recherches, actions, évaluations. In : Ed. ANRS : L'observance